Our study constitutes the first evidence of the inhibitory effect of DXC on MMP-2 enzymatic activity in both, in vitro and in vivo models, in addition to its anti-angiogenic property in proliferative retinopathies. This evidence concerns the gene MMP2 and retinal disorder.